We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Valeant Subsidiary Warned for Hiding Risks in Product Promo Piece
Valeant Subsidiary Warned for Hiding Risks in Product Promo Piece
The FDA’s Office of Prescription Drug Promotion warned a Valeant Pharmaceuticals subsidiary for failing to include risk information in promotional material for a cough suppressant.